Amarin Corp Plcuk (AMRN) Amortization of Deferred Charges (2012 - 2020)
Amarin Corp Plcuk (AMRN) posted quarterly Amortization of Deferred Charges of $34000.0 for Q4 2020, down 90.61% YoY from $362000.0 in Q1 2020, and down 69.37% sequentially from $111000.0 in Q3 2020.
Amarin Corp Plcuk (AMRN) Amortization of Deferred Charges (2012 - 2020) Analysis & Trends
Amarin Corp Plcuk has disclosed Amortization of Deferred Charges across 9 years of filings, most recently posting $34000.0 for Q4 2020.
- In Q4 2020, Amortization of Deferred Charges fell 90.61% year-over-year to $34000.0; the TTM figure through Dec 2020 stood at $635000.0 (down 61.37% YoY), while the FY2020 annual figure was $635000.0, down 61.37% from the prior year.
- Amortization of Deferred Charges declined to $34000.0 in Q4 2020, from $111000.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for AMRN reached as high as $2.6 million in Q2 2016 and fell as low as $34000.0 in Q4 2020.
- The 5-year median for Amortization of Deferred Charges is $542000.0 (2016), against an average of $728850.0.
- Annual changes were most pronounced in 2016 — Amortization of Deferred Charges soared 36.65% — and 2020, when it tumbled 90.61%.
- A 5-year view of Amortization of Deferred Charges shows it stood at $537000.0 in 2016, then advanced by 10.99% to $596000.0 in 2017, then fell by 16.78% to $496000.0 in 2018, then retreated by 27.02% to $362000.0 in 2019, then plunged by 90.61% to $34000.0 in 2020.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $34000.0, $111000.0, and $201000.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 34,000.00 |
| Dec 31, 2020 | 34,000.00 |
| Sep 30, 2020 | 111,000.00 |
| Sep 30, 2020 | 111,000.00 |
| Jun 30, 2020 | 201,000.00 |
| Jun 30, 2020 | 201,000.00 |
| Mar 31, 2020 | 289,000.00 |
| Mar 31, 2020 | 289,000.00 |
| Dec 31, 2019 | 362,000.00 |
| Dec 31, 2019 | 362,000.00 |
| Sep 30, 2019 | 404,000.00 |
| Sep 30, 2019 | 404,000.00 |
| Jun 30, 2019 | 432,000.00 |
| Jun 30, 2019 | 432,000.00 |
| Mar 31, 2019 | 446,000.00 |
| Mar 31, 2019 | 446,000.00 |
| Dec 31, 2018 | 496,000.00 |
| Dec 31, 2018 | 496,000.00 |
| Sep 30, 2018 | 547,000.00 |
| Sep 30, 2018 | 547,000.00 |